Surmodics, Inc.
← Back to SRDX Overview

Surmodics, Inc. (SRDX)

Price-to-Earnings Ratio History

P/E Ratio (TTM)

-19.95

Financial Fundamentals

SRDXQuarterly Data • 5Y View

Quarterly P/E

QuarterP/E Ratio
1997-12-31146.57
1998-03-3138.34
1998-06-3035.25
1998-09-3027.73
1998-12-3131.19
1999-03-3123.13
1999-06-3025.14
1999-09-3023.87
1999-12-3164.32
2000-03-3159.18
2000-06-3059.02
2000-09-3073.96
2000-12-31111.77
2001-03-3195.90
2001-06-30152.11
2001-09-30294.43
2001-12-31108.47
2002-03-31109.04
2002-06-3052.51
2002-09-3052.73
2002-12-3157.09
2003-03-3148.69
2003-06-3029.04
2003-09-3026.33
2003-12-3125.20
2004-03-3119.90
2004-06-30-16.62
2004-09-3019.15
2004-12-3125.14
2005-03-31-5.94
2005-06-3032.59
2005-09-3037.21
2005-12-3127.42
2006-03-31111.52
2006-06-3026.37
2006-09-3025.75
2006-12-3123.96
2007-03-3128.57
2007-06-3039.83
2007-09-30-15.97
2007-12-3143.29
2008-03-3137.11
2008-06-3042.21
2008-09-30-171.02
2008-12-314.12
2009-03-3118.74
2009-06-3027.75
2009-09-3039.41
2009-12-3151.41
2010-03-31-212.94
2010-06-30-77.75
2010-09-30-2.39
2010-12-31-136.83
2011-03-3121.86
2011-06-3012.59
2011-09-30-3.07
2011-12-3123.67
2012-03-3139.07
2012-06-3024.76
2012-09-3032.18
2012-12-3119.28
2013-03-3124.43
2013-06-3024.52
2013-09-3022.85
2013-12-3123.11
2014-03-3131.11
2014-06-3020.22
2014-09-3026.33
2014-12-3120.22
2015-03-3127.61
2015-06-3019.40
2015-09-3024.71
2015-12-3126.15
2016-03-3172.35
2016-06-3019.06
2016-09-3037.24
2016-12-3136.44
2017-03-31157.09
2017-06-30128.58
2017-09-30252.67
2017-12-31-58.33
2018-03-3181.25
2018-06-30-67.93
2018-09-30-138.96
2018-12-31120.56
2019-03-31116.66
2019-06-3095.84
2019-09-3043.11
2019-12-31942.60
2020-03-3176.96
2020-06-3059.79
2020-09-30-44.50
2020-12-31-542.73
2021-03-3123.83
2021-06-30-56.51
2021-09-30-665.66
2021-12-31-59.41
2022-03-31-38.63
2022-06-30-22.70
2022-09-30-7.18
2022-12-31-15.21
2023-03-31-10.33
2023-06-3014.97
2023-09-3016.85
2023-12-31-163.04
2024-03-31399.64
2024-06-30-19.65
2024-09-30-39.88
2024-12-31-38.59
2025-03-31-20.92
2025-06-30-19.95

* P/E ratios are calculated using trailing twelve-month (TTM) earnings.